This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Aileron Therapeutics, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Justin Noehre
Introduction
Justin Noehre is a notable inventor based in Cambridge, MA (US). He has made significant strides in the field of biochemistry, particularly through his innovative work on peptidomimetic macrocycles. His research focuses on developing new methods for treating diseases, including cancer.
Latest Patents
Justin Noehre holds a patent for peptidomimetic macrocycles. This patent, which is his only one, discloses macrocycles that comprise a helix, such as an alpha helix. These macrocycles are designed for use in treating diseases, particularly cancer. The invention includes components that target the Wnt signaling pathway, specifically the Tcf4-/3-catenin complex. This innovative approach has the potential to advance therapeutic strategies in oncology.
Career Highlights
Justin Noehre is currently associated with Aileron Therapeutics, Inc., where he continues to contribute to the field of drug development. His work is characterized by a commitment to exploring novel therapeutic avenues that can lead to improved patient outcomes.
Collaborations
Some of Justin's coworkers include Huw M Nash and Rosana Kapeller-Libermann. Their collaborative efforts contribute to the innovative environment at Aileron Therapeutics, Inc.
Conclusion
Justin Noehre's contributions to the field of biochemistry through his patent on peptidomimetic macrocycles exemplify the impact of innovative thinking in medical research. His work holds promise for advancing treatments for serious diseases like cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile